Search | IOVS | ARVO Journals

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Anatomy and Pathology/Oncology January 2021

Differential Tissue Metabolic Signatures in IgG4-Related Ophthalmic Disease and Orbital Mucosa-Associated Lymphoid Tissue Lymphoma

PDF

Hiroyuki Shimizu; Yoshihiko Usui; Ryo Wakita; Yasuko Aita; Atsumi Tomita; Kinya Tsubota; Masaki Asakage; Naoya Nezu; Hiroyuki Komatsu; Kazuhiko Umazume; Masahiro Sugimoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2021; 62(1):15. doi: https://doi.org/10.1167/iovs.62.1.15

Includes: Supplemental Content

Immunology and Microbiology September 2020

Comprehensive miRNA Analysis Using Serum From Patients With Noninfectious Uveitis

PDF

Masaki Asakage; Yoshihiko Usui; Naoya Nezu; Hiroyuki Shimizu; Kinya Tsubota; Naoyuki Yamakawa; Masakatsu Takanashi; Masahiko Kuroda; Hiroshi Goto
TAGS: micrornas, uveitis
Invest. Ophthalmol. Vis. Sci.. 2020; 61(11):4. doi: https://doi.org/10.1167/iovs.61.11.4

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Cell population having a resistance to melanoma antigen specific T cell in uveal melanoma

Kinya Tsubota; Yoshihiko Usui; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):735. doi:

ARVO Annual Meeting Abstract July 2019

Efficacy of infliximab and adalimumab for macular edema associated with uveitis

Keiko Fujii; Yoshihiko Usui; Chihiro Maehara; Kinya Tsubota; Ryosuke Mitsuhashi; Akihiko Umazume; Takeshi Kezuka; Jun-ichi Sakai; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3521. doi:

ARVO Annual Meeting Abstract July 2019

Differentiation of orbital lymphoproliferative diseases by metabolomics

Hiroyuki Shimizu; Hiroshi Goto; Yoshihiko Usui; Naoya Nezu; Kinya Tsubota; Marina Ogawa; Masaki Asakage

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3581. doi:

ARVO Annual Meeting Abstract July 2019

Determining immune-related factors of intraocular diseases by artificial intelligence methods

Naoya Nezu; Yoshihiko Usui; Masaki Asakage; Hiroyuki Shimizu; Marina Ogawa; Naoyuki Yamakawa; Chihiro Yanagida; Kinya Tsubota; Akitomo Narimatsu; Katsuhiko Maruyama; Akira Saito; Masahiko Kuroda; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5369. doi:

ARVO Annual Meeting Abstract July 2019

Epidemiology of epiretinal membrane and macular edema in a large cohort of patients with uveitis

Chihiro Yanagida; Yoshihiko Usui; Ryosuke Mitsuhashi; Kinya Tsubota; naoya nezu; Takeshi Kezuka; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6679. doi:

ARVO Annual Meeting Abstract July 2019

Association Between Axial Length and Uveitis

Marina Ogawa; Yoshihiko Usui; Kinya Tsubota; Jun-ichi Sakai; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6692. doi:

ARVO Annual Meeting Abstract July 2018

Changes in Etiologies of Uveitis in Japan

Keiko Fujii; Yoshihiko Usui; Kinya Tsubota; Akihiko Umazume; Ryosuke Mitsuhashi; Takeshi Kezuka; junichi sakai; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4162. doi:

ARVO Annual Meeting Abstract July 2018

Genetic analysis of IgG4-related ophthalmic disease using next-generation sequencing

Marina Ogawa; Yoshihiko Usui; Naoyuki Yamakawa; Kazuhiko Umazume; Kinya Tsubota; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4324. doi:

ARVO Annual Meeting Abstract July 2018

Clinical features of primary vitreoretinal lymphomas with lesions involving organs other than central nervous system

Makoto Imazeki; Yoshihiko Usui; Kinya Tsubota; Kazuhiko Umazume; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5582. doi:

ARVO Annual Meeting Abstract July 2018

Analysis of clinical features of primary vitreoretinal lymphoma followed for over 5 years

Kinya Tsubota; Yoshihiko Usui; Kazuhiko Umazume; Rei Nemoto; Motoko Shibata; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5583. doi:

ARVO Annual Meeting Abstract June 2017

Genetic alterations in IgG4-related ophthalmic disease identified using next-generation sequencing

Marina Ogawa; Yoshihiko Usui; Naoyuki Yamakawa; Kazuhiko Umazume; Kinya Tsubota; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1792. doi:

ARVO Annual Meeting Abstract June 2017

Analysis of IL-10 in the intraocular fluids of patients with infectious uveitis

Ryosuke Matsushima; Yoshihiko Usui; Takeshi Kezuka; Kinya Tsubota; Akihiko Umazume; Naoyuki Yamakawa; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2180. doi:

ARVO Annual Meeting Abstract September 2016

An effective and robust murine lens-induced myopia model evaluated with micro-CT imaging

Toshihide Kurihara; Xiaoyan Jiang; Kinya Tsubota; Kiwako Mori; Yukihiro Miwa; Yusaku Katada; Maki Miyauchi; Hidemasa Torii; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5746. doi:

ARVO Annual Meeting Abstract June 2015

Identification and Quantification of the Murine Visual Cortex Activity by Functional MRI

Kinya Tsubota; Yuji Komaki; Norio Takata; Tetsu Yoshida; Kenji F Tanaka; Hideyuki Okano; Hiroshi Goto; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3373. doi:

ARVO Annual Meeting Abstract June 2015

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Liliana P Paris; Caroline H. Johnson; Edith Aguilar; Daniel Feitelberg; Yoshihiko Usui; Kinya Tsubota; Shunichiro Ueda; Yoshihiro Wakabayashi; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5203. doi:

ARVO Annual Meeting Abstract April 2014

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

Liliana P Paris; Caroline H Johnson; Peter D Westenskow; Yoshihiko Usui; Edith Aguilar; Daniel Feitelberg; Kinya Tsubota; Shunichiro Ueda; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4926. doi:

ARVO Annual Meeting Abstract June 2013

Significance of measuring immune mediators for differentiating malignant from benign pigmented intraocular tumors

Yoshihiko Usui; Shunichiro Ueda; Yoko Okunuki; Kinya Tsubota; Kazuki Tajima; Takeshi Kezuka; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):169. doi:

ARVO Annual Meeting Abstract June 2013

Effectiveness of prophylactic intravitreal bevacizumab injection in preventing complications after vitrectomy for proliferative diabetic retinopathy

Kinya Tsubota; Yoshihiro Wakabayashi; Shunichiro Ueda; Yoshihiko Usui; Jun Suzuki; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):198. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Differential Tissue Metabolic Signatures in IgG4-Related Ophthalmic Disease and Orbital Mucosa-Associated Lymphoid Tissue Lymphoma

Comprehensive miRNA Analysis Using Serum From Patients With Noninfectious Uveitis

Cell population having a resistance to melanoma antigen specific T cell in uveal melanoma

Efficacy of infliximab and adalimumab for macular edema associated with uveitis

Differentiation of orbital lymphoproliferative diseases by metabolomics

Determining immune-related factors of intraocular diseases by artificial intelligence methods

Epidemiology of epiretinal membrane and macular edema in a large cohort of patients with uveitis

Association Between Axial Length and Uveitis

Changes in Etiologies of Uveitis in Japan

Genetic analysis of IgG4-related ophthalmic disease using next-generation sequencing

Clinical features of primary vitreoretinal lymphomas with lesions involving organs other than central nervous system

Analysis of clinical features of primary vitreoretinal lymphoma followed for over 5 years

Genetic alterations in IgG4-related ophthalmic disease identified using next-generation sequencing

Analysis of IL-10 in the intraocular fluids of patients with infectious uveitis

An effective and robust murine lens-induced myopia model evaluated with micro-CT imaging

Identification and Quantification of the Murine Visual Cortex Activity by Functional MRI

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

Significance of measuring immune mediators for differentiating malignant from benign pigmented intraocular tumors

Effectiveness of prophylactic intravitreal bevacizumab injection in preventing complications after vitrectomy for proliferative diabetic retinopathy

To View More...

You must be signed into an individual account to use this feature.